- (Asciminib) Hematology
Hematologic Reactions
JAKAVI (ruxolitinib) safety profile – Hematologic ReactionsHematologic reactions are expected and manageable 1 ...
Non Hematologic Reactions
JAKAVI (ruxolitinib) safety profile – Non Hematologic ReactionsWell-characterized and manageable safety profile 1 ...
Clinical Resources
Access educational videos and expert opinions on treatment updates on ITP.
Expert Opinion on Sustained Response Off Treatment: A Spanish Perspective
Dr....
Publications
Access educational videos and expert opinions on treatment updates on ITP.
Updated international consensus report (ICR) on the investigation
and management of primary immune thrombocytopenia
Provan D,...
Prescribing JAKAVI (ruxolitinib) for MF
Prescribing JAKAVI (ruxolitinib) for MFJAKAVI is recommended for patients with MF with symptomatic splenomegaly and/or MF-...
Myelofibrosis Disease
Myelofibrosis (MF) is one of the classical types of Philadelphia (Ph) chromosome-negative myeloproliferative neoplasm (MPN). Due to clonal proliferation of pluripotent hematopoietic stem cells, MF...